Gusong Bao Keli (骨松宝颗粒)骨松宝颗粒

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

淫羊藿是一种在国家药监局注册认定的药品。该药品含有三棱、地黄、川芎-a1418f24等成分。

该药品关联的活性成分包括:三棱San Leng、地黄rehmannia、川芎Chuan Qiong、淫羊藿Yinyang Huo、知母Zhi Mu。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:贵州富华药业有限责任公司Chinese legal name: 贵州富华药业有限责任公司。

您可以探索含有相同成分的其他药品:三棱-08a2427d成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 骨松宝颗粒) is a medicine registered with the national drug regulatory authority. It contains rehmannia and other recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 三棱San Leng, 地黄rehmannia, 川芎Chuan Qiong, 淫羊藿Yinyang Huo, 知母Zhi Mu.

Manufacturers recorded for this product: 贵州富华药业有限责任公司Chinese legal name: 贵州富华药业有限责任公司.

Explore other medicines containing the same ingredient: 三棱 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 骨松宝颗粒Recorded Chinese name: 骨松宝颗粒
  • 剂型Dosage form: 颗粒剂Granules
  • 规格Specification: 10g*12袋10 g × 12 sachets

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 贵州富华药业有限责任公司Chinese legal name: 贵州富华药业有限责任公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字Z52020006

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字Z52020006

Manufacturer

Chinese legal name: 贵州富华药业有限责任公司 (domestically manufactured)

Traditional functions

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Keep sealed.

Specification

10 g × 12 sachets

中文说明书原文Original Chinese source label

批准文号

国药准字Z52020006

生产企业

贵州富华药业有限责任公司(国产)

功能主治

补肾活血,强筋壮骨。用于骨痿(骨质疏松)引起的骨折、骨痛、骨关节炎,以及预防更年期骨质疏松。

用法用量

1.口服,一次1袋,治疗骨折及骨关节炎,一日3次。|2.预防骨质疏松,一日2次,30天为一疗程。

不良反应

尚不明确。

禁忌

尚不明确。

注意事项

如与其他药物同时使用可能会发生药物相互作用,详情请咨询医师或药师。

贮藏

密封。

规格

10g*12袋

证据Evidence

  • 批准文号: 国药准字Z52020006
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.